1-3 of 3
Özlem Anak, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of In Vivo CAR Transgene Levels in Relapsed/Refractory Pediatric and Young Adult ALL and Adult DLBCL Tisagenlecleucel-Treated Patients

Rakesh Awasthi, PhD, Karen Thudium Mueller, PharmD,MSc, Gregory A. Yanik, MD, Constantine S. Tam, MBBS (Hons), MD FRACP, FRCPA, Susana Rives, MD PhD, Joseph P. McGuirk, DO, Michael A. Pulsipher, MD, Michael W. Boyer, MD, Ulrich Jaeger, MD, Andre Baruchel, MD, Gary Douglas Myers, MD, Hyatt Balke-Want, MD, Stephen J. Schuster, MD, Heather Stefanski, MD PhD, Michael R. Bishop, MD, Edward R. Waldron, PhD MSc, BSc, Özlem Anak, MD, Abhijit Chakraborty, PhD, Eric Bleickardt, MD, Stephane Wong, PhD MBA, Lida Bubuteishvili Pacaud, MD, Edmund K. Waller, MD, Shannon L. Maude, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 899.
https://doi.org/10.1182/blood-2018-99-116385
Published: 2018
Journal Articles

Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial of Tisagenlecleucel

Stephen J. Schuster, MD, Michael R. Bishop, MD, Constantine Tam, MD PhD, Peter Borchmann, MD, Ulrich Jaeger, MD, Edmund K. Waller, MD, Harald Holte, MD PhD, Joseph P. McGuirk, DO, Samantha Jaglowski, MDMPH, Kensei Tobinai, MD PhD, Charalambos Andreadis, MD MSCE, Isabelle Fleury, Stephan Mielke, MD, Takanori Teshima, Jason R. Westin, MD, Veronika Bachanova, MD PhD, Stephen Ronan Foley, MD FRCPC, P Joy Ho, MBBS(Syd) DPhil(Oxon) FRACP FRCPA FFSc(RCPA), John M. Magenau, MD, Nina D. Wagner-Johnston, MD, Koji Kato, MD PhD, Marie Jose Kersten, MD PhD, Koen Van Besien, MD PhD, Jufen Chu, PhD, Aline Jary, MS, Özlem Anak, MD, Gilles Salles, MD PhD, Richard Thomas T. Maziarz, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1684.
https://doi.org/10.1182/blood-2018-99-115252
Published: 2018
Journal Articles

Safety and Efficacy of Tisagenlecleucel Treatment in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL) and No Evidence of Active Disease Following Bridging Chemotherapy in the JULIET Trial

Michael R. Bishop, MD, Richard Thomas T. Maziarz, MD, Edmund K. Waller, MD, Christopher del Corral, PharmD, Ranjan Tiwari, MSc, Özlem Anak, MD, Rakesh Awasthi, PhD, Vadim V. Romanov, MD MPhil, FFPM, Stephen J. Schuster, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2958.
https://doi.org/10.1182/blood-2018-99-115094
Published: 2018